Mycophenolic Acid-Mediated Suppression of Human CD4+ T Cells: More Than Mere Guanine Nucleotide Deprivation-Reference-Cited by-同舟云学术

Mycophenolic Acid-Mediated Suppression of Human CD4+ T Cells: More Than Mere Guanine Nucleotide Deprivation

Published:2011-02-22 Issue:3 Volume:11 Page:439-449
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

He X.,Smeets R. L.,Koenen H. J. P. M.,Vink P. M.,Wagenaars J.,Boots A. M. H.,Joosten I.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2010.03413.x/fullpdf

Reference29 articles.

1. Mycophenolate mofetil;Zwerner;Dermatol Ther,2007

2. What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?;Jones;Curr Opin Rheumatol,2009

3. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway;Santos;Oncogene,2001

4. Mycophenolate mofetil inhibits T cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP;Sankatsing;Transpl Int,2008

5. Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human T-lymphocytes;Qiu;Transplantation,2000

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cryptococcosis Associated With Biologic Therapy: A Narrative Review;Open Forum Infectious Diseases;2024-06-26

2. Optimal exposure of mycophenolic acid for induction therapy of childhood lupus nephritis patients: an observational cohort study;Rheumatology;2024-05-10

3. In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV;Transplant International;2024-04-09

4. Cellular Immunobiology and Molecular Mechanisms in Alloimmunity—Pathways of Immunosuppression;Transplantation;2023-12-13

5. Drug exporter expression correlates with group 3 innate lymphoid cell resistance to immunosuppressive agents;Frontiers in Hematology;2023-08-25